Physicians' and Machine Learning Researchers’ Perspectives on Ethical Issues in the Development of Clinical Machine Learning Tools: A Qualitative Interview Study
ABSTRACT
Background:
Innovative tools leveraging machine learning and artificial intelligence (ML/AI) are rapidly being developed for medicine, with new applications emerging in prediction, diagnosis, and treatment across a range of illnesses, patient populations, and clinical procedures.
Objective:
One challenge for successful innovation is the absence, to date, of a robust ethical framework informed by the perspectives of ML/AI researchers and physicians.
Methods:
To help articulate these perspectives, we conducted 21 semi-structured interviews with a purposive sample of ML/AI researchers (n = 10) and physicians (n = 11). We asked interviewees about their views regarding ethical considerations related to the adoption of ML/AI in medicine.
Results:
Notably, both researchers and physicians described concerns regarding how ML/AI innovations are shaped in early phases even prior to their development and implementation (which from here on will be referred to as the “problem formulation” phase). Considerations encompassed assessment of research priorities and motivations, clarity and centeredness of clinical needs, professional and demographic diversity of research teams, and interdisciplinary knowledge generation and collaboration.
Conclusions:
These qualitative findings help to elucidate several ethical challenges anticipated or encountered in ML/AI for health care.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.